Susquehanna International Group, LLP Pro Qr Therapeutics N.V. Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 26,500 shares of PRQR stock, worth $45,050. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,500
Previous 67,054 60.48%
Holding current value
$45,050
Previous $183,000 80.87%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.81 - $4.49 $44,944 - $111,491
24,831 Added 58.81%
67,054 $183,000
Q3 2024

Nov 14, 2024
SELL
$1.64 - $2.24 $88,387 - $120,724
-53,895 Reduced 56.07%
42,223 $76,000
Q2 2024

Aug 15, 2024
SELL
$1.65 - $2.39 $72,654 - $105,238
-44,033 Reduced 31.42%
96,118 $159,000
Q1 2024

May 07, 2024
BUY
$1.89 - $2.85 $238,487 - $359,624
126,184 Added 903.44%
140,151 $320,000
Q4 2023

Feb 14, 2024
SELL
$1.15 - $2.21 $30,639 - $58,881
-26,643 Reduced 65.61%
13,967 $27,000
Q3 2023

Nov 14, 2023
BUY
$1.3 - $1.77 $52,793 - $71,879
40,610 New
40,610 $52,000
Q4 2022

Feb 14, 2023
BUY
$0.8 - $3.7 $131,856 - $609,837
164,821 New
164,821 $609,000
Q2 2022

Aug 15, 2022
BUY
$0.56 - $1.0 $535 - $956
956 Added 2.48%
39,565 $31,000
Q4 2021

Feb 14, 2022
SELL
$6.58 - $8.44 $589,943 - $756,705
-89,657 Reduced 69.9%
38,609 $309,000
Q3 2021

Nov 15, 2021
BUY
$5.16 - $8.47 $440,700 - $723,397
85,407 Added 199.27%
128,266 $1.07 Million
Q2 2021

Aug 11, 2021
SELL
$5.75 - $7.59 $123,044 - $162,418
-21,399 Reduced 33.3%
42,859 $289,000
Q1 2021

May 17, 2021
BUY
$4.14 - $9.22 $266,028 - $592,458
64,258 New
64,258 $425,000
Q3 2020

Nov 16, 2020
SELL
$4.79 - $6.3 $55,089 - $72,456
-11,501 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$4.5 - $6.53 $5,656 - $8,208
-1,257 Reduced 9.85%
11,501 $70,000
Q1 2020

May 15, 2020
SELL
$5.25 - $9.9 $20,947 - $39,501
-3,990 Reduced 23.82%
12,758 $70,000
Q4 2019

Feb 14, 2020
BUY
$5.84 - $10.51 $97,808 - $176,021
16,748 New
16,748 $166,000
Q2 2018

Aug 14, 2018
SELL
$2.95 - $7.45 $46,919 - $118,492
-15,905 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$2.9 - $3.5 $40,542 - $48,930
-13,980 Reduced 46.78%
15,905 $49,000
Q4 2017

Feb 14, 2018
BUY
$2.8 - $4.8 $83,678 - $143,448
29,885
29,885 $96,000

Others Institutions Holding PRQR

# of Institutions
69
Shares Held
42.1M
Call Options Held
30.1K
Put Options Held
5.3K
View Full List

About ProQR Therapeutics N.V.

PRQR Quotes by TradingView
  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $121M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email